Disease/Infection News

RSS

Gilead Sciences' sofosbuvir MAA gets EMA validation

Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.

22 May 2013

Exposure to air pollution during prenatal period is associated with increased risk of respiratory infection in children

Living near a major roadway during the prenatal period is associated with an increased risk of respiratory infection developing in children by the age of 3, according to a new study from researchers in Boston.

21 May 2013

IBD patients are at higher risk of melanoma, report researchers

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla.

21 May 2013

Study: 3/4 women experience constipation and other bowel disorders during their pregnancies

Nearly three out of four pregnant women experience constipation, diarrhea or other bowel disorders during their pregnancies, a Loyola University Medical Center study has found.

21 May 2013

TB clinical drug trials in jeopardy due to federal sequestration funding cuts

Innovative and potentially game-changing clinical trials to develop new drug regimens to prevent and treat tuberculosis, the second leading global infectious disease killer, are in jeopardy due to federal "sequestration" funding cuts.

21 May 2013

Childhood respiratory infections rather than analgesics usage linked to risk for asthma

A new study conducted by Boston researchers reports that the link between asthma and early childhood use of acetaminophen or ibuprofen may be driven by underlying respiratory infections that prompt the use of these analgesics, rather than the drugs themselves.

21 May 2013

Groundbreaking germ-fighting vaccine research to be presented at National Biotechnology Conference

A novel vaccine study from South Dakota State University will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' National Biotechnology Conference.

21 May 2013

Research explores pharmaceutical advances for IBS, hepatitis C

Research presented at Digestive Disease Week explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea and hepatitis C.

21 May 2013

New diagnostic test for lymphatic filariasis

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field study in Liberia, in West Africa, where the infection is endemic.

21 May 2013

New computer model predicts when avian influenza strain becomes infectious

A new computer model could help scientists predict when a particular strain of avian influenza might become infectious from bird to human, according to a report to be published in the International Journal Data Mining and Bioinformatics.

21 May 2013

Certain varieties of clay have ability to kill MRSA, says ASU researcher

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

20 May 2013

Tips to keep dog park visits safe, healthy for dogs and dog owners

Dog parks are a great place to socialize dogs and let them play, but they also have some hidden dangers, according to a Kansas State University veterinarian.

20 May 2013

Peer-referral program can bring more patients into emergency departments for HIV testing

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the hospital for testing.

18 May 2013

AOAC international certification validates Biótica's Legipid Legionella Fast Detection Test

The AOAC international certification has validated Biótica's MP4-Hunter. The system developed by the company settled at the Science Park in the Universitat Jaume I de Castellón (Spain) enables to perform up to 40 Legionella tests per analyst in an hour.

18 May 2013

Sorrento Therapeutics' anti-MRSA program gets NIAID support

Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award.

18 May 2013

Thioridazine works by weakening staphylococcal cell wall, new study reveals

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as staphylococci (Staphylococcus aureus).

18 May 2013

New LAMP malaria test to improve diagnosis for imported UK cases

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to new research published in the Journal of Infectious Diseases.

17 May 2013

WHO: Single dose of vaccination sufficient to confer life-long immunity against yellow fever disease

The yellow fever 'booster' vaccination given ten years after the initial vaccination is not necessary, according to WHO.

17 May 2013

A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 influenza vaccine

Singapore's Agency for Science, Technology and Research and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle technology.

17 May 2013

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions.

17 May 2013

Disease/Infection News

Gilead Sciences' sofosbuvir MAA gets EMA validation

Exposure to air pollution during prenatal period is associated with increased risk of respiratory infection in children

IBD patients are at higher risk of melanoma, report researchers

Study: 3/4 women experience constipation and other bowel disorders during their pregnancies

TB clinical drug trials in jeopardy due to federal sequestration funding cuts

Childhood respiratory infections rather than analgesics usage linked to risk for asthma

Groundbreaking germ-fighting vaccine research to be presented at National Biotechnology Conference

Research explores pharmaceutical advances for IBS, hepatitis C

New diagnostic test for lymphatic filariasis

New computer model predicts when avian influenza strain becomes infectious

Certain varieties of clay have ability to kill MRSA, says ASU researcher

Tips to keep dog park visits safe, healthy for dogs and dog owners

Peer-referral program can bring more patients into emergency departments for HIV testing

AOAC international certification validates Biótica's Legipid Legionella Fast Detection Test

Sorrento Therapeutics' anti-MRSA program gets NIAID support

Thioridazine works by weakening staphylococcal cell wall, new study reveals

New LAMP malaria test to improve diagnosis for imported UK cases

WHO: Single dose of vaccination sufficient to confer life-long immunity against yellow fever disease

A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 influenza vaccine

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News